LeT wanted to kill Bal Thackeray, Headley tells court

March 24, 2016

Mumbai, Mar 24: Pakistani-American terrorist David Headley, convicted in the US for his role in the 26/11 Mumbai attacks, today told a court here that terror outfit Lashkar-e-Taiba (LeT) wanted to eliminate Bal Thackeray but the person who was assigned the job to kill the late Shiv Sena chief was arrested.

HeadleyThe 55-year-old, who has turned approver in the terror case, disclosed this fact during a cross-examination on the second day by Abdul Wahab Khan, the lawyer of Abu Jundal, an alleged key plotter of the 2008 Mumbai terror attacks, via a video link from the US.

Headley also told the court that he had visited the Sena Bhavan twice. He, however, did not specify the year for the same.

"We wanted to target the chief of Shiv Sena... His name was Bal Thackeray. LeT wanted to kill him wherever a chance arose. I knew that Bal Thackeray was the head of Shiv Sena. I have no first hand knowledge but I think an attempt was made by LeT to kill Bal Thackeray," he said.

"I don't know how this attempt was made. I think the person (who was sent to kill Thackeray) was arrested but he managed to escape from police custody. I don't have first hand knowledge about this though," Headley added.

He also told special judge G A Sanap, who is hearing the 26/11 terror case against Jundal in a sessions court here, that he does not know who else was a target of LeT apart from Thackeray.

Yesterday, Headley spilled the beans on how once US financed his trip to Pakistan and also claimed that he had "donated" about Rs 70 lakh to LeT till 2006, two years before the Mumbai attacks.

He, however, contradicted reports that he had received money from LeT.

"I never received money from LeT... This is complete nonsense. I gave funds to LeT myself. I had donated more than 60 to 70 lakh Pakistani Rupees to LeT throughout the period I was associated with them. My last donation was in 2006," Headley told the court.

He also said that after his arrest in 1998, the Drug Enforcement Authority (DEA) of the US had financed his trip.

Also, the terrorist, who faced conviction twice in 1988 and 1998 for alleged drug smuggling before the Mumbai siege, had indulged in criminal activities and violated his plea bargain agreements with the US government, the court was told.

Headley, who is serving a 35-year jail term in the US, also told the court that Tahawwur Rana, his associate and a Pakistani native who operated an immigration business in Chicago, was aware that he was an operative of LeT.

Headley had also disclosed that Rana had once come to Mumbai just prior to the 26/11 strikes, and that the latter continued his association with him till Headley's arrest.

He, however, refused to answer questions about his wife Shazia and reveal her location, whether she is in the US or Pakistan, or her father's name.

"Shazia is still my legally wedded wife. I do not want to disclose Shazia's location at present. I do not want to answer any question about my wife Shazia," he said.

When Khan continued questioning him on Shazia, Special Public Prosecutor Ujjwal Nikam took objection to it and said that under Section 122 of the Indian Evidence Act, the communication between a husband and wife is a privileged one and need not be disclosed.

The Pakistani-American terrorist had earlier concluded his week-long deposition before the Mumbai sessions court through a video-link from the US on February 13.

Headley, in his earlier deposition, said how Pakistan's intelligence agency ISI provides "financial, military and moral support" to terror outfits LeT, Jaish-e-Mohammad and Hizbul Mujahideen, and how LeT planned and executed the 26/11 Mumbai attack.

He had also claimed that Ishrat Jahan, killed in an allegedly fake encounter in Gujarat, was an LeT operative.

Comments

Curious
 - 
Friday, 25 Mar 2016

America might have sent and financed similar kind to attack Paris Brussels saudi and other countries . And later act like peace keeper in world.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 19,2020

New Delhi, Jul 19: Blaming the BJP for the political drama in Rajasthan, senior Congress leader Digvijaya Singh on Sunday asked Sachin Pilot not to leave the grand old party.

In an interview to news agency, the former Madhya Pradesh chief minister said Pilot should not follow Jyotiraditya Scindia into the BJP, as he has bright future in Congress.

His remarks follow Pilot's open rebellion against the Ashok Gehlot government, which has been on shaky ground with at least 18 legislators backing the rebel leader.

Pilot was sacked as Rajasthan deputy chief minister and the state Congress chief recently and the Congress has accused the BJP of making efforts to topple the Gehlot-led government by indulging in horse-trading.

"The BJP is behind the crisis in Rajasthan," Singh said.

The Congress veteran said he tried to call Pilot but his calls and text messages went unanswered.

"Age is on your side. Ashok (Gehlot) may have offended you, but all such issues are best resolved amicably. Dont make the mistake that Scindia made. BJP is unreliable. Nobody who joined it from any other party has succeeded there," Singh said.

He said this is the first time that Pilot hasn't responded to him.

"Sachin is like my son. He respects me and I also like him. I called him three-four times and also texted him. He didn't revert. He used to respond immediately earlier," he said.

"It is good to be ambitious. How can one move forward without having ambitions, but along with ambition, one must also have commitment to your organisation, ideology and the nation," Singh said.

For latest updates on the Rajathan Political Crisis, click here

"I heard that he (Pilot) may form a new party. But what is the need for it. Has Congress not given him anything? He was made an MP at 26, a Union minister at 32, the state Congress president at 34 and deputy chief minister at 38. What else does he want? Time is on his side," Singh said.

If Pilot had any issue, then as the state party unit president, he should have called a meeting and discussed the matter, he said. Pilot could have involved Congress national general secretary and Rajasthan in-charge Avinash Pande in talks with Gehlot to resolve differences, he added.

"If you have faith in your legislators, why have you have confined 18-19 of them in ITC Grand hotel at Manesar in Haryana," Singh said.

This is the same hotel where the BJP kept MLAs from Maharashtra, Karnataka and Madhya Pradesh (during political dramas in those states), he said.

Pilot should forget whatever has happened, come back and sit across the table to discuss how Congress could be strengthened, he said

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 8,2020

New Delhi, Jul 8: India has reported a spike of 22,752 COVID-19 cases in the last 24 hours, taking the country's coronavirus tally to 7,42,417 on Wednesday, informed the Union Ministry of Health and Family Welfare.

Out of the total cases reported, 4,56,830 patients have been cured/discharged from the disease while one patient has been migrated, the Health Ministry informed.

It added that there are 2,64,944 active cases in the country.

482 deaths reported in the last 24 hours due to COVID-19 in the country, taking India's death toll to 20,642.

According to the Union Health Ministry, Maharashtra continues to be the worst affected state reporting 2,17,121 coronavirus cases and 9,250 fatalities.

Tamil Nadu -- the second worst-affected state from COVID-19 -- has a total of 1,18,594 cases and 1,636 deaths due to coronavirus.

While Delhi has a total of 1,02,831 COVID-19 cases including 3,165 deaths.

The Indian Council of Medical Research on Wednesday informed that a total of 1,04,73,771 samples tested for COVID-19 up to July 7. Of these, 2,62,679 samples were tested on Tuesday.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 3,2020

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of the Oxford University developed Covid-19 vaccine candidate in the country.

Government officials said that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after a thorough evaluation based on the recommendations of the Subject Expert Committee (SEC) on Covid-19.

"The firm has to submit safety data, evaluated by the Data Safety Monitoring Board (DSMB), to the CDSCO before proceeding to phase 3 clinical trials," a senior official said.

"As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on day 29) following which the safety and immunogenicity will be assessed at predefined intervals," the official said.

As a rapid regulatory response, the expert panel at the Central Drugs Standard Control Organisation (CDSCO) on Friday, after a detailed deliberation and considering the data generated on the vaccine candidate in phase 1 and 2 of the Oxford University trial, had recommended granting permission for phase 2 and 3 clinical trials of the potential vaccine, 'Covishield', on healthy adults in India,  the officials said.

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.

The officials said that the SII had submitted a revised proposal on Wednesday after the SEC on July 28, following deliberation over its application, had asked it to revise its protocol for the phase 2 and 3 clinical trials besides seeking some additional information.

The panel had also recommended that the clinical trial sites which have been proposed for the study be distributed across India.

According to the revised proposal by the SII, 1,600 people aged above 18 years will participate in the trials across 17 selected sites, including AIIMS-Delhi, B J Medical College in Pune, Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Post Graduate Institute of Medical Education and Research in Chandigarh, AIIMS-Jodhpur, Nehru Hospital in Gorakhpur, Andhra Medical College in Visakhapatnam and JSS Academy of Higher Education and Research in Mysore.

"According to the application, it would conduct an observer-blind, randomised controlled study to determine the safety and immunogenicity of 'Covishield' on healthy Indian adults," the official said.

The SII, which has partnered with AstraZeneca, for manufacturing the Oxford vaccine candidate for Covid-19 had submitted its first application to the DCGI on July 25 seeking permission for conducting the phase 2 and 3 trials of the potential vaccine. 

Initial results of the first two-phases of trials of the vaccine conducted in five trial sites in the UK showed that it has an acceptable safety profile and homologous boosting increased antibody response, sources had said.

To introduce the vaccine, SII, the world's largest vaccine maker by number of doses produced and sold, has signed an agreement to manufacture the potential vaccine developed by the Jenner Institute (Oxford University) in collaboration with British-Swedish pharma company AstraZeneca. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.